148 related articles for article (PubMed ID: 23140760)
1. Taking the starch out of hereditary colorectal cancer.
Boland CR
Lancet Oncol; 2012 Dec; 13(12):1179-80. PubMed ID: 23140760
[No Abstract] [Full Text] [Related]
2. Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
Mathers JC; Movahedi M; Macrae F; Mecklin JP; Moeslein G; Olschwang S; Eccles D; Evans G; Maher ER; Bertario L; Bisgaard ML; Dunlop M; Ho JW; Hodgson S; Lindblom A; Lubinski J; Morrison PJ; Murday V; Ramesar R; Side L; Scott RJ; Thomas HJ; Vasen H; Gerdes AM; Barker G; Crawford G; Elliott F; Pylvanainen K; Wijnen J; Fodde R; Lynch H; Bishop DT; Burn J;
Lancet Oncol; 2012 Dec; 13(12):1242-9. PubMed ID: 23140761
[TBL] [Abstract][Full Text] [Related]
3. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
Burn J; Gerdes AM; Macrae F; Mecklin JP; Moeslein G; Olschwang S; Eccles D; Evans DG; Maher ER; Bertario L; Bisgaard ML; Dunlop MG; Ho JW; Hodgson SV; Lindblom A; Lubinski J; Morrison PJ; Murday V; Ramesar R; Side L; Scott RJ; Thomas HJ; Vasen HF; Barker G; Crawford G; Elliott F; Movahedi M; Pylvanainen K; Wijnen JT; Fodde R; Lynch HT; Mathers JC; Bishop DT;
Lancet; 2011 Dec; 378(9809):2081-7. PubMed ID: 22036019
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic colectomy for gene carriers in hereditary nonpolyposis colorectal cancer. Has the time come?
RodrÃguez-Bigas MA
Cancer; 1996 Jul; 78(2):199-201. PubMed ID: 8673992
[No Abstract] [Full Text] [Related]
5. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations.
Syngal S; Weeks JC; Schrag D; Garber JE; Kuntz KM
Ann Intern Med; 1998 Nov; 129(10):787-96. PubMed ID: 9841584
[TBL] [Abstract][Full Text] [Related]
6. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
Yang F; Jin C; Fu D
N Engl J Med; 2009 Apr; 360(14):1461-2; author reply 1462-3. PubMed ID: 19339729
[No Abstract] [Full Text] [Related]
7. Dietary fibre and human cancer. Epidemiological data.
Hill MJ
Adv Exp Med Biol; 1997; 427():27-34. PubMed ID: 9361827
[No Abstract] [Full Text] [Related]
8. Genetic testing may prevent hereditary nonpolyposis colorectal cancer. Hamilton Fairley Lecture, held at the ESMO Congress, Vienna, November 2-5, 1996.
de la Chapelle A
Ann Oncol; 1996 Nov; 7(9):883-5. PubMed ID: 9006737
[No Abstract] [Full Text] [Related]
9. Chemoprevention in Lynch syndrome.
Burn J; Mathers JC; Bishop DT
Fam Cancer; 2013 Dec; 12(4):707-18. PubMed ID: 23880960
[TBL] [Abstract][Full Text] [Related]
10. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
Topping DL; Bird AR; Young GP
N Engl J Med; 2009 Apr; 360(14):1462; author reply 1462-3. PubMed ID: 19348022
[No Abstract] [Full Text] [Related]
11. Aspirin and colorectal cancer prevention in Lynch syndrome.
Chan AT; Lippman SM
Lancet; 2011 Dec; 378(9809):2051-2. PubMed ID: 22036018
[No Abstract] [Full Text] [Related]
12. Predicting and preventing hereditary colorectal cancer.
Ford JM; Whittemore AS
JAMA; 2006 Sep; 296(12):1521-3. PubMed ID: 17003401
[No Abstract] [Full Text] [Related]
13. Establishment of a registry for hereditary nonpolyposis colorectal cancer in New Zealand.
Jass JR; Stewart SW; Chapman CJ; Lane MR
N Z Med J; 1993 Jul; 106(960):309-11. PubMed ID: 8341456
[No Abstract] [Full Text] [Related]
14. Hereditary nonpolyposis colorectal cancer (Lynch syndrome): new insights from genetic linkage.
Rustgi AK; Nakagawa H; Yan YX
Gastroenterology; 1994 Mar; 106(3):815-7. PubMed ID: 8119556
[No Abstract] [Full Text] [Related]
15. If aggressive surveillance in hereditary nonpolyposis colorectal cancer is now state of the art, are there any challenges left?
Lynch P
Gastroenterology; 2000 May; 118(5):969-71. PubMed ID: 10784597
[No Abstract] [Full Text] [Related]
16. Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer.
Diergaarde B; Braam H; Vasen HF; Nagengast FM; van Muijen GN; Kok FJ; Kampman E
Clin Gastroenterol Hepatol; 2007 Jun; 5(6):736-42. PubMed ID: 17544999
[TBL] [Abstract][Full Text] [Related]
17. Hereditary colorectal cancer.
Lynch HT; de la Chapelle A
N Engl J Med; 2003 Mar; 348(10):919-32. PubMed ID: 12621137
[No Abstract] [Full Text] [Related]
18. Evaluation of genetic testing for hereditary non-polyposis colorectal cancer (HNPCC).
Walpole IR
Med J Aust; 2000 Apr; 172(7):308-9. PubMed ID: 10844913
[No Abstract] [Full Text] [Related]
19. Does aspirin really reduce the risk of colon cancer?
Cleland JG
Lancet; 2012 Apr; 379(9826):1586; author reply 1587. PubMed ID: 22541575
[No Abstract] [Full Text] [Related]
20. Does aspirin really reduce the risk of colon cancer?
Jankowski J; Barr H; Moayyedi P
Lancet; 2012 Apr; 379(9826):1586-7; author reply 1587. PubMed ID: 22541573
[No Abstract] [Full Text] [Related]
[Next] [New Search]
